In vivo tumor imaging using a novel RNAi-based detection mechanism

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 4, 2012, Pages 393-398

  Wan, Kayiu ^a   Ebert, Bernd ^b   Voigt, Jan ^b   Wang, Qing ^a   Dai, Yiyang ^a   Haag, Rainer ^c   Kemmner, Wolfgang ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Molecular imaging; Protoporphyrin IX; Silencing of ferrochelatase

Indexed keywords

CANCER TISSUES; CANCEROUS TISSUES; DETECTION MECHANISM; DOWN-REGULATION; ENDOGENOUS FLUORESCENCE; FERROCHELATASE; HEME SYNTHESIS; IN-VIVO; IN-VIVO EXPERIMENTS; NUDE MICE; PROTOPORPHYRIN IX; TUMOR IMAGING; TUMOR TISSUES;

FLUORESCENCE; HIGH ENERGY PHYSICS; LIPOSOMES; METABOLITES; MOLECULAR IMAGING; PHOSPHOLIPIDS; PROBES;

TUMORS;

FERROCHELATASE; LIPOSOME; NANOPARTICLE; POLYGLYCEROLAMINE NANOPARTICLE; PROTOPORPHYRIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; FLUORESCENCE; IMAGING; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; TUMOR IMAGING;

ANIMALS; COLORECTAL NEOPLASMS; FEMALE; FERROCHELATASE; FLUORESCENCE; HUMANS; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTOPORPHYRINS; RNA PROBES; RNA, MESSENGER; RNA, NEOPLASM; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 84862815180     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.02.004     Document Type: Article

References (12)

1. Moesta K.T., Ebert B., Handke T., Nolte D., Nowak C., Haensch W.E., et al. Protoporphyrin IX occurs naturally in colorectal cancers and their metastases. Cancer Res 2001, 61:991-999.
2. Peng Q., Warloe T., Moan J., Godal A., Apricena F., Giercksky K.E., et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res 2001, 61:5824-5832.
3. Oo M.K., Yang X., Du H., Wang H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomed 2008, 3:777-786.
4. Kemmner W., Wan K., Ruttinger S., Ebert B., MacDonald R., Klamm U., et al. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 2008, 22:500-509.
5. Takakura Y., Nishikawa M., Yamashita F., Hashida M. Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery. J Drug Target 2002, 10:99-104.
6. Felgner P.L., Ringold G.M. Cationic liposome-mediated transfection. Nature 1989, 337:387-388.
7. Ofek P., Fischer W., Calderon M., Haag R., Satchi-Fainaro R. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J 2010, 24:3122-3134.
8. Ishizuka M., Abe F., Sano Y., Takahashi K., Inoue K., Nakajima M., et al. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol 2011, 11:358-365.
9. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
10. Loh C.S., MacRobert A.J., Bedwell J., Regula J., Krasner N., Bown S.G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993, 68:41-51.
11. Anand S., Honari G., Hasan T., Elson P., Maytin E.V. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res 2009, 15:3333-3343.
12. Tschaharganeh D., Ehemann V., Nussbaum T., Schirmacher P., Breuhahn K. Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference. Pathol Oncol Res 2007, 13:84-90.